All In MedTech

Device Trial Radar · NCT05642650

Novel Wearable Device for Heart Failure Management

Clinical Translational Research of Novel Wearable Device Based on Patented Sensing Technology in Non-Invasive Management of Heart Failure

Last checked: Nov 19, 2026Latest source record: Nov 5, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Not yet recruitingPivotal-lookingRandomized with 108 participants. This is a heuristic, not a regulatory label.

Status

Not yet recruiting

Enrollment

108

Planned (sponsor's estimate)

Start

Apr 28, 2027

Primary completion

Apr 28, 2029

Study completion Apr 28, 2029

Sponsor

Lead sponsor
China-Japan Friendship HospitalAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Dec 8, 2022

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Screening
FDA-regulated device
No
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Heart failure (HF) is a major cardiovascular disease with high readmission and mortality rate. A wearable device that could remotely monitor and detect the worsening HF early before the symptoms appear will help reduce HF readmissions effectively. The purpose of the current study is to examine the efficiency of a novel wearable device based on flexible strain sensor comparing to the clinical 'gold standard,' and then transform it into a clinical application.

Conditions

  • Heart Failure

Interventions

  • novel wearable deviceDevice

    Patients with a novel wearable device for monitoring and uploading data daily to collect monitoring data such as jugular vein pressure and exercise steps after discharge.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Rate of Hospital Readmissions for Heart FailureTime frame: Up to 6 months

Locations

No sites are listed on the registry yet.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.